Cargando…

CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity

Chimeric antigen receptor (CAR) T cell therapy represents a significant advancement in cancer therapy. Larger studies have shown ∼90% complete remission rates against chemoresistant and/or refractory CD19(+) leukemia or lymphoma. Effective CAR T cell therapy is highly dependent on lymphodepleting pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kueberuwa, Gray, Kalaitsidou, Milena, Cheadle, Eleanor, Hawkins, Robert Edward, Gilham, David Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772011/ https://www.ncbi.nlm.nih.gov/pubmed/29367945 http://dx.doi.org/10.1016/j.omto.2017.12.003

Ejemplares similares

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
por: Kueberuwa, Gray, et al.
Publicado: (2018)

Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer
por: Owens, Gemma L., et al.
Publicado: (2018)

CCR7(+) selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo
por: Kueberuwa, Gray, et al.
Publicado: (2017)

Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
por: Owens, Gemma L., et al.
Publicado: (2018)

Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice
por: Mulazzani, Matthias, et al.
Publicado: (2019)

Transgenic T-cell receptor immunotherapy for cancer: building on clinical success
por: Oppermans, Natasha, et al.
Publicado: (2020)

IL-23 and PSMA-targeted duo-CAR T cells in Prostate Cancer Eradication in a preclinical model
por: Wang, Dawei, et al.
Publicado: (2020)

Commentary: Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice
por: Hocine, Hocine Rachid, et al.
Publicado: (2020)

In vivo generated human CAR T cells eradicate tumor cells
por: Agarwal, Shiwani, et al.
Publicado: (2019)

Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes
por: Kalaitsidou, Milena, et al.
Publicado: (2023)

Safety and feasibility of anti-CD19 CAR T cells with fully-human binding domains in patients with B-cell lymphoma
por: Brudno, Jennifer N., et al.
Publicado: (2020)

Evidence of clinical efficacy of a first generation CD19 CAR T cell in B cell malignancies
por: Shohdy, Kyrillus S., et al.
Publicado: (2023)

Cable‐Car Electrocatalysis to Drive Fully Decoupled Water Splitting
por: Long, Yuanzheng, et al.
Publicado: (2023)

Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology
por: Lontos, Konstantinos, et al.
Publicado: (2022)

Eradicating Malaria by Way of the Human Host
Publicado: (1916)

Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumors
por: Fang, Lin, et al.
Publicado: (2023)

Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneity
por: Cazaux, Marine, et al.
Publicado: (2019)

PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models
por: Zuccolotto, Gaia, et al.
Publicado: (2014)

Induction heating for eradicating Staphylococcus epidermidis from biofilm
por: Pijls, Bart G., et al.
Publicado: (2020)

Lymphoma immunotherapy: Efficacy, safety and accessibility to CAR-T therapy for lymphomas
por: Borchmann, Peter
Publicado: (2018)

CAR T-cell therapy for follicular lymphoma and mantle cell lymphoma
por: Mohty, Razan, et al.
Publicado: (2022)

RAPID VIRAL INDUCTION OF MURINE LYMPHOMAS IN THE GRAFT-VERSUS-HOST REACTION
por: Cornelius, Eugene A.
Publicado: (1972)

HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma
por: Xu, Xueer, et al.
Publicado: (2023)

IL-15 Enhances the Persistence and Function of BCMA-Targeting CAR-T Cells Compared to IL-2 or IL-15/IL-7 by Limiting CAR-T Cell Dysfunction and Differentiation
por: Battram, Anthony M., et al.
Publicado: (2021)

CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma
por: Su, Lihe, et al.
Publicado: (2022)

CAR-Based Approaches to Cutaneous T-Cell Lymphoma
por: Scarfò, Irene, et al.
Publicado: (2019)

CAR-T Cell Therapy for Classical Hodgkin Lymphoma
por: Katsin, Mikalai, et al.
Publicado: (2023)

Candida Biofilms and the Host: Models and New Concepts for Eradication
por: Tournu, Hélène, et al.
Publicado: (2012)

Lymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy
por: Lim, Lucy Y., et al.
Publicado: (2015)

CAR T-Cell Therapy for Large B-Cell Lymphoma
por: Alencar, Maritza C.
Publicado: (2019)

CAR T-Cells for CNS Lymphoma: Driving into New Terrain?
por: Karschnia, Philipp, et al.
Publicado: (2021)

CAR T-Cell therapy for the management of mantle cell lymphoma
por: Huang, Zoufang, et al.
Publicado: (2023)

Recent advances in CAR T-cell therapy for lymphoma in China
por: Che, Yuxuan, et al.
Publicado: (2023)

CAR-T Cell Therapy in Large B Cell Lymphoma
por: Testa, Ugo, et al.
Publicado: (2023)

Improving Hashimoto’s thyroiditis by eradicating Blastocystis hominis: Relation to IL-17
por: El-Zawawy, Hanaa Tarek, et al.
Publicado: (2020)

The consequences of reservoir host eradication on disease epidemiology in animal communities
por: Al-Shorbaji, Farah, et al.
Publicado: (2016)

Arms Race between Enveloped Viruses and the Host ERAD Machinery
por: Frabutt, Dylan A., et al.
Publicado: (2016)

Inhibition and Eradication of Pseudomonas aeruginosa Biofilms by Host Defence Peptides
por: Chen, Hongwei, et al.
Publicado: (2018)

Using the Power of Junctional Adhesion Molecules Combined with the Target of CAR-T to Inhibit Cancer Proliferation, Metastasis and Eradicate Tumors
por: Mendoza, Christopher, et al.
Publicado: (2022)

Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells
por: Jiang, Hua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kavpadqmkmc1q7tfsb00dg8f3v